Lifecore Biomedical, Inc. \De\ (LFCR) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2025 value amounting to -$8.9 million.
- Lifecore Biomedical, Inc. \De\'s Gains from Investment Securities fell 718114.75% to -$8.9 million in Q2 2025 from the same period last year, while for May 2025 it was -$7.8 million, marking a year-over-year decrease of 32538.29%. This contributed to the annual value of -$7.8 million for FY2025, which is 32538.29% down from last year.
- According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Gains from Investment Securities is -$8.9 million, which was down 718114.75% from -$1.6 million recorded in Q1 2025.
- Lifecore Biomedical, Inc. \De\'s Gains from Investment Securities' 5-year high stood at $2.1 million during Q4 2024, with a 5-year trough of -$8.9 million in Q2 2025.
- In the last 5 years, Lifecore Biomedical, Inc. \De\'s Gains from Investment Securities had a median value of $55000.0 in 2023 and averaged -$1.0 million.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 849200.0% in 2024, then tumbled by 718114.75% in 2025.
- Lifecore Biomedical, Inc. \De\'s Gains from Investment Securities (Quarter) stood at $84000.0 in 2021, then surged by 69.05% to $142000.0 in 2022, then plummeted by 82.39% to $25000.0 in 2023, then skyrocketed by 8492.0% to $2.1 million in 2024, then crashed by 513.55% to -$8.9 million in 2025.
- Its Gains from Investment Securities was -$8.9 million in Q2 2025, compared to -$1.6 million in Q1 2025 and $2.1 million in Q4 2024.